Pharmaceuticals News

Revenue and EBITDA margin expectations increased, driven by stronger-than-expected Travel Health sales COPENHAGEN, Denmark, October 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced an...

Forventningerne til omsætning og EBITDA-margin er opjusteret som følge af et stærkere salg i Travel Health end forventet. KØBENHAVN, Danmark, 8. oktober 2026 – Bavarian Nordic A/S (OMX: BAVA)...

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, October 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...

October 8, 2026, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will discontinue the Phase 3 UNITY...

Study met primary endpoint of change from baseline in the ratio of Vh:Cd (p=0.0176)First Phase 2 evidence that blocking CD122 can prevent gluten-induced intestinal damage in people living with...

The Botswana subsidiary expands Bio Usawa’s international presence, joining the company’s existing operations in Rwanda, Kenya, and Germany.

Optogenetic therapy proved safe in blind patients and led to a clinically meaningful increase in light sensitivity in six, marking a major milestone.

Lifecore Biomedical to Participate at Upcoming Industry Conferences

HIGH POINT, N.C., Oct. 07, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for...

Lyon (France), October 07, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that, following a further benefit-risk assessment of IXCHIQ® for...